| Rank | Holder | SharesFloat % | Change | Date reported |
|---|---|---|---|---|
| 1 | FMR Inc | 4.54M (17.29%) | -153.65K Decreased by -3.39% | Sep 30, 23 |
| 2 | Perceptive Advisors LLC | 3.97M (15.11%) | -50.42K Decreased by -1.27% | Sep 30, 23 |
| 3 | SR ONE CAPITAL MANAGEMENT, LP | 3.95M (15.04%) | 0.00 Increased by 0.00% | Sep 30, 23 |
| 4 | NEA Management Company, LLC | 3.75M (14.27%) | 0.00 Increased by 0.00% | Sep 30, 23 |
| 5 | Paradigm Biocapital Advisors LP | 2.95M (11.25%) | 606.12K Increased by +20.52% | Sep 30, 23 |
| 6 | Suvretta Capital Management, LLC | 2.87M (10.93%) | 21.80K Increased by +0.76% | Sep 30, 23 |
| 7 | BlackRock Inc | 2.71M (10.32%) | 105.18K Increased by +3.88% | Sep 30, 23 |
| 8 | Cormorant Asset Management, LLC | 2.15M (8.19%) | 150.00K Increased by +6.98% | Sep 30, 23 |
| 9 | Vanguard Group Inc | 2.04M (7.77%) | 43.97K Increased by +2.16% | Sep 30, 23 |
| 10 | State Street Corporation | 2.01M (7.67%) | 82.48K Increased by +4.09% | Sep 30, 23 |
| 11 | HHG PLC | 1.78M (6.76%) | 21.19K Increased by +1.19% | Sep 30, 23 |
| 12 | Lord, Abbett & Co LLC | 1.10M (4.18%) | -167.34K Decreased by -15.24% | Sep 30, 23 |
| 13 | Novo A/S | 1.07M (4.10%) | 75.00K Increased by +6.98% | Sep 30, 23 |
| 14 | T. Rowe Price Associates, Inc. | 936.87K (3.57%) | -120.91K Decreased by -12.91% | Sep 30, 23 |
| 15 | T. Rowe Price Investment Management,Inc. | 910.18K (3.47%) | 910.18K Increased by +100.00% | Sep 30, 23 |
| 16 | Goldman Sachs Group Inc | 874.86K (3.33%) | -144.06K Decreased by -16.47% | Sep 30, 23 |
| 17 | Geode Capital Management, LLC | 739.05K (2.82%) | 53.83K Increased by +7.28% | Sep 30, 23 |
| 18 | Soleus Capital Management, L.P. | 643.78K (2.45%) | -358.22K Decreased by -55.64% | Sep 30, 23 |
| 19 | Samsara BioCapital, LLC | 613.92K (2.34%) | 0.00 Increased by 0.00% | Sep 30, 23 |
| 20 | JPMorgan Chase & Co | 563.90K (2.15%) | 236.46K Increased by +41.93% | Sep 30, 23 |
| Rank | Holder | SharesFloat % | Change | Date reported |
|---|---|---|---|---|
| 1 | Fidelity® Select Biotechnology | 1.19M (4.54%) | -167.40K Decreased by -14.04% | Nov 30, 23 |
| 2 | Vanguard Total Stock Mkt Idx Inv | 1.17M (4.48%) | 1.97K Increased by +0.17% | Nov 30, 23 |
| 3 | iShares Russell 2000 ETF | 1.02M (3.89%) | 6.49K Increased by +0.64% | Dec 29, 23 |
| 4 | SPDR® S&P Biotech ETF | 993.16K (3.78%) | -5.76K Decreased by -0.58% | Dec 31, 23 |
| 5 | Lord Abbett Developing Growth A | 598.27K (2.28%) | -159.16K Decreased by -26.60% | Nov 30, 23 |
| 6 | Janus Henderson Global Life Sciences | 502.50K (1.91%) | 14.70K Increased by +2.93% | Sep 30, 23 |
| 7 | Janus Henderson Global Life Sciences D | 502.50K (1.91%) | 14.70K Increased by +2.93% | Sep 30, 23 |
| 8 | Select Health Care | 500.00K (1.90%) | 0.00 Increased by 0.00% | Oct 31, 23 |
| 9 | Fidelity Select Health Care | 472.02K (1.80%) | -27.98K Decreased by -5.93% | Nov 30, 23 |
| 10 | Vanguard Institutional Extnd Mkt Idx Tr | 450.93K (1.72%) | 10.83K Increased by +2.40% | Nov 30, 23 |
| 11 | UBS: US Equity Small Cap Growth | 444.31K (1.69%) | 0.00 Increased by 0.00% | Sep 30, 23 |
| 12 | Candriam Global Equities Oncology | 398.00K (1.52%) | 0.00 Increased by 0.00% | Sep 30, 23 |
| 13 | Fidelity® Small Cap Growth | 383.78K (1.46%) | -466.00 Decreased by -0.12% | Oct 31, 23 |
| 14 | Janus Selection Global Life Science AUSD | 382.62K (1.46%) | -2.30K Decreased by -0.60% | Sep 30, 23 |
| 15 | T. Rowe Price Small-Cap Stock | 378.30K (1.44%) | 378.30K Increased by +100.00% | Sep 30, 23 |
| 16 | T. Rowe Price US Small-Cap Core Equity | 378.30K (1.44%) | 378.30K Increased by +100.00% | Sep 30, 23 |
| 17 | US Small-Cap Growth II Equity Comp | 372.04K (1.42%) | 372.04K Increased by +100.00% | Jun 30, 23 |
| 18 | T. Rowe Price New Horizons | 371.92K (1.42%) | -127.00 Decreased by -0.03% | Sep 30, 23 |
| 19 | Pictet-Biotech P USD | 369.43K (1.41%) | -74.68K Decreased by -20.21% | May 31, 23 |
| 20 | Fidelity® Small Cap Index | 365.52K (1.39%) | 9.74K Increased by +2.66% | Oct 31, 23 |